MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Ivonescimab

  1. Home
  2. Drugs
  3. Ivonescimab
  4. Clinical Trials

Clinical Trials Related to Ivonescimab

Related studies linked through entity extraction aliases.

NCT06790212

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

Status
NOT_YET_RECRUITING
Phase
PHASE2

NCT06769971

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

Status
RECRUITING
Phase
PHASE2

NCT06672575

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Status
RECRUITING
Phase
PHASE1/PHASE2

NCT06567314

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Status
RECRUITING
Phase
PHASE2

NCT06529718

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Status
RECRUITING
Phase
PHASE2

NCT06491472

Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer

Status
RECRUITING
Phase
PHASE2

NCT06478043

A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC

Status
NOT_YET_RECRUITING
Phase
PHASE2

NCT06196697

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Status
RECRUITING
Phase
PHASE2

NCT05582499

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

Status
RECRUITING
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.